BioNTech plays down takeover talk ahead of COVID-19 vaccine trial

BioNTech plays down takeover talk ahead of COVID-19 vaccine trial

Source: 
Pharmaforum
snippet: 

Germany’s BioNTech has said it is not interested in a takeover after it gained clearance to begin a high-profile COVID-19 coronavirus vaccine trial with Pfizer.